Pancreas transcription factor 1α expression is regulated in pancreatitis

European Journal of Clinical Investigation

Volumn 37, Issue 10, 2007, Pages 791-801

  Molero, X ^a,e   Adell, T ^b   Skoudy, A ^b   Padilla, M A ^b   Gomez J A ^a,e   Chalaux, E ^b,c   Malagelada, J R ^a,e   Real, F X ^b,c,d  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Chronic pancreatitis; Differentiation; Pancreas; Pancreatic regeneration; Pancreatitis; Transcription factor

Indexed keywords

CERULETIDE; CHOLECYSTOKININ OCTAPEPTIDE[28,31 N METHYLNORLEUCINE]; CYCLOSPORIN A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 1 ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CHRONIC DISEASE; CONTROLLED CLINICAL TRIALS AS TOPIC; GENE EXPRESSION REGULATION; PANCREAS; PANCREATITIS; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; REGENERATION; TRANSCRIPTION FACTORS;

EID: 34748870224     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01856.x     Document Type: Article

References (52)

1. Boreham B, Ammori BJ. A prospective evaluation of pancreatic exocrine function in patients with acute pancreatitis: correlation with extent of necrosis and pancreatic endocrine insufficiency. Pancreatology 2003 3 : 303 8.
2. Bozkurt T, Maroske D, Adler G. Exocrine pancreatic function after recovery from necrotizing pancreatitis. Hepatogastroenterology 1995 42 : 55 8.
3. DiMagno EP, Layer P, Clain JE. Chronic pancreatitis. In : Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, (Eds). The Pancreas. Biology, Pathobiology, and Disease. New York : Raven Press 1993, pp. 665 706.
4. Elsässer HP, Adler G, Kern HF. Time course and cellular source of pancreatic regeneration following acute pancreatitis in the rat. Pancreas 1986 1 : 421 9.
5. Whitcomb DC. Hereditary pancreatitis: a model for understanding the genetic basis of acute and chronic pancreatitis. Pancreatology 2001 1 : 565 70.
6. Reber HA, Adler G, Karanjia N, Widdison A. Permeability characteristics of the main pancreatic duct in cats: Models of acute and chronic pancreatitis. In : Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, (Eds). The Pancreas. Biology, Pathobiology, and Disease. New York : Raven Press 1993, pp. 527 50.
7. Gasslander T, Ihse I, Smeds S. The importance of the centroacinar region in caerulein-induced mouse pancreatic growth. Scand J Gastroenterol 1992 27 : 564 70.
8. Mitchel RM, Byrne MF, Baillie J. Pancreatitis. Lancet 2003 361 : 1447 55.
9. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Eng J Med 1993 328 : 1433 7.
10. Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK, Perrault J et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997 89 : 442 6.
11. Real FX. A 'catastrophic' hypothesis for pancreas cancer progression. Gastroenterology 1993 124 : 1958 64.
12. Kruse F, Rose SD, Swift GH, Hammer RE, MacDonald RJ. Cooperation between elements of an organ-specific transcriptional enhancer in animals. Mol Cell Biol 1995 15 : 4385 94.
13. Roux E, Strubin M, Hagenbüchle O, Wellauer PK. The cell-specific transcription factor PTF1 contains two different subunits that interact with the DNA. Genes Dev 1989 3 : 1613 24.
14. Sommer L, Hagenbüchle O, Wellauer PK, Strubin M. Nuclear targeting of the transcription factor PTF1 is mediated by a protein subunit that does not bind the PTF1 cognate sequence. Cell 1991 67 : 987 94.
15. Adell T, Gomez-Cuadrado A, Skoudy A, Pettengill OS, Longnecker DS, Real FX. Role of the basic helix-loop-helix transcription factor p48 in the differentiation phenotype of exocrine pancreas cancer cells. Cell Growth Differ 2000 11 : 137 47.
16. Krapp A, Knofler M, Frutiger S, Hughes GJ, Hagenbuchle O, Wellauer PK. The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein. EMBO J 1996 15 : 4317 29.
17. Beres TM, Masui T, Swift GH, Shi L, Henke RM, Macdonald RJ. PTF1 is an organ-specific and notch-independent basic helix-loop-helix complex containing the mammalian suppressor of hairless (RBP-J) or its paralogue, RBP-L. Mol Cell Biol 2006 26 : 117 30.
18. Adell T, Skoudy A, Gomez-Cuadrado A, Palomero T, Real FX. The bHLH transcription factor p48 in exocrine pancreas differentiation in vitro. In : Gress TM, (Eds). Molecular Pathogenesis of Pancreatic Cancer. Amsterdam : IOS Press 2000, pp. 80 7.
19. Liu Y, MacDonald RJ, Swift GH. DNA binding and transcriptional activation by a PDX1.PBX1b.MEIS2b trimer and cooperation with a pancreas-specific basic helix-loop-helix complex. J Biol Chem 2001 276 : 17985 93.
20. Krapp A, Knofler M, Ledermann B, Burki K, Berney C, Zoerkler N et al. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev 1998 12 : 3752 63.
21. Kawaguchi Y, Cooper B, Gannon M, Ray M, MacDonald RJ, Wright CV. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 2002 32 : 128 34.
22. Bort R, Zaret K. Paths to the pancreas. Nat Genet 2002 32 : 85 6.
23. Rodolosse A, Chalaux E, Adell T, Hagege H, Skoudy A, Real FX. PTF-1α/p48 transcription factor couples cell proliferation to cell differentiation in the exocrine pancreas. Gastroenterology 2004 127 : 937 49.
24. Gomez JA, Molero X, Vaquero E, Alonso A, Salas A, Malagelada JR. Vitamin E attenuates biochemical and morphological features associated with development of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2004 287 : G162 9.
25. Puig-Diví V, Molero X, Salas A, Guarner F, Malagelada J-R. Induction of chronic pancreatitis disease by trinitrobenzene sulfonic acid infusion into rat pancreatic ducts. Pancreas 1996 13 : 417 24.
26. Vaquero E, Molero X, Tian X, Salas A, Malagelada JR. Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats. Gut 1999 45 : 269 77.
27. Schüssler MH, Skoudy A, Ramaekers FCS, Real FX. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 1992 140 : 559 68.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-DeltaDeltaC (T) Method. Methods 2001 25 : 402 8.
29. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ. Early NF-kB activation is associated with hormone-induced pancreatitis. Am J Physiol 1998 275 : G1402 14.
30. Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM. NF-kB/Rel activation in caerulein pancreatitis. Gastroenterology 1999 116 : 420 30.
31. Tando Y, Algül H, Magner M, Weidenbach H, Adler G, Schmid RM. Caerulein-induced NF-KB/Rel activation requires both Ca2+ and protein kinase C as messengers. Am J Physiol 1999 277 : G678 86.
32. Bierkamp C, Bonhoure S, Mathieu A, Clerc P, Fourmy D, Pradayrol L et al. Expression of the Cholecystokinin-2/Gastrin receptor (CCK-2R) in the murine modulates cell adhesion and cell differentiation in vivo. Am J Pathol 2004 165 : 2135 45.
33. Christophe J. Pancreatic tumoral cell line AR42J: an amphicrine model. Am J Physiol 1994 266 : G963 71.
34. Zhou W, Povoski SP, Longnecker DS, Bell RH. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Cancer Res 1992 52 : 6905 11.
35. Saillan-Barreau C, Clerc P, Adato M, Escrieut C, Vaysse N, Fourmy D et al. Transgenic CCK-B/gastrin receptor mediates murine exocrine pancreatic secretion. Gastroenterology 1998 115 : 988 96.
36. Williams JA, Blevins GT. Cholecystokinin and regulation of pancreatic acinar function. Physiol Rev 1993 73 : 701 23.
37. Real FX. The cell biology of pancreatic cancer: an overview. In : Neoptolemos J, Lemoine NR, (Eds). Pancreatic Cancer. Oxford : Blackwell Science Press 1995, pp. 3 17.
38. Scarpelli DG, Rao MS, Reddy JK. Are acinar cells involved in the pathogenesis of ductal adenocarcinoma of the pancreas? Cancer Cells 1991 3 : 275 7.
39. Schmid RM. Acinar-to-ductal metaplasia in pancreatic cancer development. J Clin Invest 2002 109 : 1403 4.
40. Vilá MR, Lloreta J, Real FX. Normal human pancreas cultures display functional ductal characteristics. Lab Invest 1994 71 : 423 31.
41. Jensen JN, Cameron E, Garay MV, Starkey TW, Gianani R, Jensen J. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 2005 128 : 728 41.
42. Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003 3 : 565 76.
43. Maruyama H, Kleeff J, Wildi S, Friess H, Buchler MW, Israel MA et al. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol 1999 155 : 815 22.
44. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H. Beta-cell specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998 12 : 1763 8.
45. Dutta S, Bonner-Weir S, Montminy MR, Wright C. Regulatory factor linked to late-onset diabetes? Nature 1998 392 : 560.
46. Gomez G, Englander EW, Wang G, Greeley GH Jr. Increased expression of hypoxia-inducible factor-1alpha, p48, and the Notch signaling cascade during acute pancreatitis in mice. Pancreas 2004 28 : 58 64.
47. van Westerloo DJ, Florquin S, de Boer AM, Daalhuisen J, de Vos AF, Bruno MJ et al. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 2005 166 : 721 8.
48. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997 15 : 106 10.
49. Stoffers DA, Ferrer J, Clarke WL, Habeber JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997 17 : 138 9.
50. Hani EH, Stoffers DA, Chevre JC, Durand E, Stanojevic V, Dina C et al. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 1999 104 : R41 8.
51. Macfarlane WM, Frayling TM, Ellard S, Evans JC, Allen LI, Bulman MP et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999 104 : R33 9.
52. Sellick GS, Barker KT, Stolte-Dijkstra T, Fleischmann C, Coleman RJ, Garrett C et al. Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 2004 36 : 1301 5.